Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Mavura, Daudi R; Masenga, E John; Minja, Eli et al. (2015) Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania. Int J Dermatol 54:68-73
Scott, Lesley E; Crump, John A; Msuya, Emma et al. (2011) Abbott RealTime HIV-1 m2000rt viral load testing: manual extraction versus the automated m2000sp extraction. J Virol Methods 172:78-80
Crump, John A; Ramadhani, Habib O; Morrissey, Anne B et al. (2011) Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania. Trop Med Int Health 16:830-7
Tribble, A C; Hamilton, C D; Crump, J A et al. (2009) Missed opportunities for diagnosis of tuberculosis and human immunodeficiency virus co-infection in Moshi, Tanzania. Int J Tuberc Lung Dis 13:1260-6
Williams, Pl; Wu, Jw; Cohn, Se et al. (2009) Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV Med 10:290-301
Skowron, Gail; Spritzler, John G; Weidler, Jodi et al. (2009) Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects. J Acquir Immune Defic Syndr 50:250-8
Seshadri, C; Uiso, L O; Ostermann, J et al. (2008) Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients. East Afr Med J 85:442-9
Tebas, Pablo; Henry, William Keith; Matining, Roy et al. (2008) Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. PLoS One 3:e2021
Landman, Keren Z; Ostermann, Jan; Crump, John A et al. (2008) Gender differences in the risk of HIV infection among persons reporting abstinence, monogamy, and multiple sexual partners in northern Tanzania. PLoS One 3:e3075
Hare, C Bradley; Mellors, John; Krambrink, Amy et al. (2008) Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis 47:421-4

Showing the most recent 10 out of 41 publications